Sign in
4

Changes in Ownership

Benitec Biopharma Inc. Filed Acc 0001062993-23-022118

Options or other derivatives

  • Director acquired 35,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
BUCHI J KEVIN Director 2023-12-06 Grant or award · Options (right to buy) +35,000 35,000 D: show line 1 in the form
Loading xslF345X05/form4.xml…